Jefferies Group LLC restated a "buy" rating and issued a $183.00 target price on shares of Cigna Corporation in a research note on Thursday, June 8th. On August 7 Morgan Stanley held the stock rating at "Overweight" and raised the price target to $188.00 from $184.00. Morgan Stanley increased their price target on shares of Cigna Corporation from $188.00 to $195.00 and gave the company an "overweight" rating in a research report on Thursday, August 17th.
Among 17 analysts covering CIGNA (NYSE:CI), 15 have Buy rating, 0 Sell and 2 Hold. Finally, Royal Bank Of Canada restated a "buy" rating and issued a $177.00 target price on shares of Cigna Corporation in a research note on Tuesday, June 13th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of "Buy" and an average price target of $182.59. Rhumbline Advisers holds 0.15% of its portfolio in CIGNA Corporation (NYSE:CI) for 448,665 shares. Company shares last traded at $186.05 just a bit higher than the 50 day moving average of $179.52 and which is quite a bit above the 200 day moving average of $165.10.
The company now has a P/E ratio of 21.47 and the market value is 46.84B. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $188.36.
Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. LLC now owns 43,600 shares of the health services provider's stock valued at $7,298,000 after buying an additional 1,200 shares in the last quarter. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The firm had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter in the prior year, the company earned $1.98 EPS. The business's quarterly revenue was up 3.6% compared to the same quarter previous year. In the last earnings report the EPS was $8.67 and is estimated to be $10.02 for the current year with 251,778,000 shares now outstanding. If you are reading this piece on another domain, it was illegally copied and republished in violation of United States and global copyright and trademark legislation. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & worldwide trademark & copyright legislation. The legal version of this article can be read at https://weekherald.com/2017/09/17/piper-jaffray-companies-reiterates-buy-rating-for-cigna-corporation-ci.html. It is flat, as 53 investors sold CI shares while 249 reduced holdings. only 73 funds opened positions while 187 raised stakes.
On July 13 Deutsche Bank made no change to the stock rating of "Buy" and raised the price expectation from $125.00 to $180.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Matthew G. Manders, Pres. Gov't & Ind Prog & Group let go of $4,262,719 worth of shares at a price of $175.01 on July 21st. Triplett Michael W also sold $240,153 worth of CIGNA Corporation (NYSE:CI) shares. Another trade for 275 shares valued at $9,349 was made by Johnson Betty R. on Monday, May 8. The disclosure for this sale can be found here. Insiders sold a total of 223,821 shares of company stock valued at $38,506,877 in the last quarter. Corporate insiders own 1.30% of the company's stock.
A number of institutional investors and hedge funds have recently modified their holdings of CI. Parallel Advisors LLC grew its position in Cigna Corporation by 62.3% in the 2nd quarter. The President, US Markets now owns $3,684,658 of the stock as reported to the SEC.
Squarepoint Ops LLC grew its ownership by buying 46,117 shares an increase of 75.5% as of 06/30/2017. Ahl Partners Llp now owns 96,012 shares valued at $16,071,000. American Beacon Advisors Inc. bought a new position in Cigna Corporation in the 1st quarter valued at $102,000. Cantab Capital Partners Llp claims 18,687 shares worth $3,128,000,000. Beaton Management Co. Inc. bought a new stake in shares of Cigna Corporation in the 2nd quarter valued at approximately $298,000. Finally, Dynamic Technology Lab Private Ltd increased its holdings in Cigna Corporation by 255.4% in the second quarter. Dynamic Technology Lab Private Ltd now owns 6,752 shares of the health services provider's stock valued at $1,130,000 after purchasing an additional 4,852 shares during the period. Following the completion of the transaction, the chief executive officer now directly owns 421,162 shares of the company's stock, valued at $71,681,772.40.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company.